Imaging of Lymphatic Anomalies



Status:Completed
Conditions:Lymphoma, Lymphoma, Women's Studies
Therapuetic Areas:Oncology, Reproductive
Healthy:No
Age Range:2 - 80
Updated:4/17/2018
Start Date:April 2016
End Date:December 2017

Use our guide to learn which trials are right for you!

Dynamic Contrast Enhanced MR Lymphangiogram Imaging of Lymphatic Anomalies (LA)

Lymphatic Anomalies (LA) is characterized by proliferation of lymphatic tissue causing
deterioration of pulmonary function. Understanding changes in lymphatic anatomy in these
patients is hindered by the difficulty of imaging the lymphatic system. Dynamic Contrast
Enhanced MR Lymphangiogram (DCMRL) may be useful in investigating pathological changes in the
lymphatic system.

Lymphatic anomalies (LA) are a spectrum of rare diseases classified into lymphatic tumors and
malformations. Complicated LA cases in the past have been called lymphangiomatosis because of
varied disseminated involvement including soft tissue and viscera such as the spleen, liver
and bone. Pleural effusions and pericardial effusions are often associated with these
lesions. These are now classified into different phenotypes such as Generalized Lymphatic
Anomaly (GLA), Gorham's Stout Disease (GSD) and Kaposiform Lymphangiomatosis (KLA). These
complicated phenotypes can cause massive osteolysis causing a morbidity and mortality from
infection or paralysis or worsening pulmonary function and effusions (GSD, GLA, KLA).

The major cause of mortality and morbidity in these patients is the deterioration of
pulmonary function by chronic chylous effusions and progressive interstitial lung disease.
Unfortunately, little is known about biomarkers, risk stratification or the pathophysiology
of this progression. The understanding of changes in patients' lymphatic anatomy with LA is
hindered by the difficulty of imaging the lymphatic system. Dynamic Contrast Enhanced MR
Lymphangiogram (DCMRL) is a technique that has recently been developed, allowing dynamic MR
imaging of the lymphatic system by injecting gadolinium contrast agent in the groin lymph
nodes.

This technique has been previously used to identify pathological lymphatic perfusion of the
lung parenchyma in patients with plastic bronchitis and neonatal chylothorax. Based on these
imaging findings, a treatment algorithm has been designed and used to successfully treat the
majority of those patients with these conditions.

Inclusion Criteria:

- Subjects diagnosed with Lymphatic Anomalies (GLA, KL, Gorham disease) with
radiological and or pathological confirmation of lung involvement will be considered
for the study.

- Girls > 11 y.o. with a negative urine pregnancy test and contraception use.

- Registration in the International Lymphangiomatosis and Gorham's Disease Alliance
(LGDA) Patient Registry or referral by a physician.

Exclusion Criteria:

- Subjects with contraindications to contrast enhanced MRI: allergy to gadolinium
imaging agents, impaired renal function (GFR<30) and presence of paramagnetic objects.

- Claustrophobia or contraindications to sedation/anesthesia

- Uncorrectable coagulopathy (bleeding disorders).

- Pregnant or lactating females.
We found this trial at
1
site
South 34th Street
Philadelphia, Pennsylvania 19104
 215-590-1000
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials